Company Filing History:
Years Active: 2013
Title: Innovations in Cancer Treatment by Johannes Humer
Introduction
Johannes Humer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies. His research focuses on the melanoma-associated endogenous retrovirus, which has implications for cancer diagnosis and treatment.
Latest Patents
Johannes Humer holds a patent for "Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein." This invention provides antibodies, or fragments thereof, for isolating and identifying epitopes of an endogenous retrovirus, specifically targeting melanoma-associated endogenous retroviruses. The antibodies developed through this patent are particularly useful for the treatment and diagnosis of cancer. Furthermore, the patent includes diagnostic kits for detecting cancer cells, especially melanoma cells, and methods for cancer diagnosis utilizing these antibodies.
Career Highlights
Humer is currently associated with Baxter Healthcare SA, where he continues to advance his research in the medical field. His work has garnered attention for its potential to improve cancer treatment options and diagnostic methods.
Collaborations
Johannes Humer has collaborated with esteemed colleagues, including Bernd Mayer and Thomas Muster. Their combined expertise contributes to the innovative research and development of cancer therapies.
Conclusion
Johannes Humer's contributions to cancer research through his patented innovations highlight the importance of scientific advancements in medical treatment. His work not only aids in the diagnosis of melanoma but also paves the way for future developments in cancer therapy.